TODAY’S HEADLINES:
- IlluminOss Medical gets $11M for bone-fracture devices (peHUB)
- Contract researcher Crown Bioscience takes in funding (release)
IlluminOss Medical gets $11M for bone-fracture devices — East Providence, R.I.-based IlluminOss Medical, a medical-device startup, raised $11 million in a second funding round, peHUB reports. Backers included New Leaf Ventures and Foundation Medical Partners.
The company’s Web site is barely more than a stub that describes IlluminOss as a device company “pioneering new frontiers in orthopedic surgery.” peHUB offers the further tidbit that the company is developing a minimally invasive system for treating bone fractures.
We’ve previously covered Sonoma Orthopedics Products, a California firm with what may be a similar technology for treating fractures with an implant that supposedly speeds healing from inside the bone.
Contract researcher Crown Bioscience takes in funding – Crown Bioscience, a biology-services startup in Santa Clara, Calif., raised an undisclosed sum in a second funding round. Chemizon, a division of Optomagic, provided the cash.
Crown offers a variety of biology-based services, including protein characterization, drug-candidate discovery and assessment of anticancer drugs. In other words, it’s a contract-research organization, although it seems to have a wider range of offerings that many CROs do.
Tags: biotechnology, bone fractures, co:Crown Bioscience, co:IlluminOss Medical, contract-research, deal, inv:Chemizon, inv:Foundation-Medical-Partners, inv:New-Leaf-Ventures, medical-devices